Effects of glucose and blood pressure control on complications of type 2 diabetes mellitus

Cleveland Clinic Journal of Medicine

Volumn 66, Issue 4, 1999, Pages 247-253

  Nasr, Christian E ^b   Hoogwerf, Byron J ^b   Faiman, Charles ^b   Reddy, S Sethu K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CHLORPROPAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; GLUCOSE; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

BLOOD PRESSURE REGULATION; DIABETES CONTROL; DIABETES MELLITUS; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; ADULT; AGED; ARTICLE; BLOOD PRESSURE; METABOLISM; MIDDLE AGED; OBESITY; PATIENT SELECTION; PROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; GREAT BRITAIN; HUMANS; HYPERTENSION; MIDDLE AGED; OBESITY; PATIENT SELECTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0033109316     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.66.4.247     Document Type: Review

References (11)

1. UK Prospective Diabetes Study Group. Intensive blood-glucose control with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-853.
2. UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes mellitus (UKPDS 34). Lancet 1998; 352:854-865.
3. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998; 317:703-713.
4. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39). BMJ 1998; 317:713-720.
5. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18: 258-268
6. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 43:960-967.
7. University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 1970; 19(Suppl 2):747-830.
8. DCCT Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial. N Engl J Med 1993; 329:978-986.
9. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6-year study. Diabet Res Clin Pract 1995; 28:103-117.
10. UK Prospective Diabetes Study Group. A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in noninsulin-dependent diabetes mellitus (UKPDS 17). Ann Intern Med 1996; 124 (1 pt 2):136-145.
11. Turner RC. The UK prospective diabetes study: a review. Diabetes Care 1998; 21(Suppl 3):C35-C38.